Imagin Medical Inc News - IME

IMI to Present at 16th Annual Wall Street Analyst Forum in New York

IMI to Present at 16th Annual Wall Street Analyst Forum in New York TORONTO, Feb. 16 /PRNewswire-FirstCall/ -- Predictive medicine company...

PREVU(x) POC Skin Sterol Test available for sale in Canada, U.S. markets

PREVU(x) POC Skin Sterol Test available for sale in Canada, U.S. markets TORONTO, Jan. 27 /PRNewswire-FirstCall/ -- IMI International...

IMI to exhibit at 19th Annual Financial Forum in Toronto

IMI to exhibit at 19th Annual Financial Forum in Toronto TORONTO, Jan. 19 /PRNewswire-FirstCall/ -- Predictive medicine company...

New skin sterol data published in Journal of Clinical Chemistry

New skin sterol data published in Journal of Clinical Chemistry TORONTO, Jan. 12 /PRNewswire-FirstCall/ -- Predictive medicine company...

IMI expands skin sterol research with study examining new cardiovascular disease markers

IMI expands skin sterol research with study examining new cardiovascular disease markers TORONTO, Jan. 5 /PRNewswire-FirstCall/ -- Predictive...

IMI announces decision not to pursue IBEX Technologies Inc.

IMI announces decision not to pursue IBEX Technologies Inc. TORONTO, Dec. 16 /PRNewswire-FirstCall/ -- IMI International Medical Innovations...

New Skin Sterol data to be presented at American College of Cardiology Annual Conference

New Skin Sterol data to be presented at American College of Cardiology Annual Conference TORONTO, Dec. 9 /PRNewswire-FirstCall/ -- Predictive...

IMI granted new skin sterol patent in Europe

IMI granted new skin sterol patent in Europe Strengthens positioning of PREVU(x) Skin Sterol Test in key markets, including U.K. TORONTO, Dec. 8...

IMI announces new PREVU(x) study with Montreal Heart Institute

IMI announces new PREVU(x) study with Montreal Heart Institute Successful completion of study could lead to additional regulatory approvals...

IMI announces third quarter results

IMI announces third quarter results TORONTO, Nov. 11 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX:IMI; Amex: IME...

IMI to hold third quarter fiscal 2004 conference call & webcast

IMI to hold third quarter fiscal 2004 conference call & webcast TORONTO, Nov. 11 /PRNewswire-FirstCall/ -- IMI International Medical Innovations...

IMI announces unsolicited takeover offer for IBEX Technologies Inc.

IMI announces unsolicited takeover offer for IBEX Technologies Inc. - Premium of 45% for IBEX shareholders based on November 1, 2004 closing...

Skin sterol provides new information about heart disease risk

Skin sterol provides new information about heart disease risk CALGARY, Oct. 26 /PRNewswire-FirstCall/ -- The ability to identify those...

IMI to Present at Rodman & Renshaw Healthcare Conference

IMI to Present at Rodman & Renshaw Healthcare Conference TORONTO, Oct. 14 /PRNewswire-FirstCall/ -- Predictive medicine company...

IMI International Medical Innovations Retains New York-Based Investor Relations Firm

IMI International Medical Innovations Retains New York-Based Investor Relations Firm TORONTO, Aug. 31 /PRNewswire-FirstCall/ -- IMI...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Imagin Medical Inc (IME)

Empower your portfolio: Real-time discussions and actionable trading ideas.

IME News

IMI to Present at 16th Annual Wall Street Analyst Forum in New York

PREVU(x) POC Skin Sterol Test available for sale in Canada, U.S. markets

IMI to exhibit at 19th Annual Financial Forum in Toronto

New skin sterol data published in Journal of Clinical Chemistry

IMI expands skin sterol research with study examining new cardiovascular disease markers

IMI announces decision not to pursue IBEX Technologies Inc.

New Skin Sterol data to be presented at American College of Cardiology Annual Conference

IMI granted new skin sterol patent in Europe

IMI announces new PREVU(x) study with Montreal Heart Institute

IMI announces third quarter results

IMI to hold third quarter fiscal 2004 conference call & webcast

IMI announces unsolicited takeover offer for IBEX Technologies Inc.

Skin sterol provides new information about heart disease risk

IMI to Present at Rodman & Renshaw Healthcare Conference

IMI International Medical Innovations Retains New York-Based Investor Relations Firm

IME Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Imagin Medical Inc (IME) News

Imagin Medical Inc (IME)

Empower your portfolio: Real-time discussions and actionable trading ideas.

IME News

IMI to Present at 16th Annual Wall Street Analyst Forum in New York

PREVU(x) POC Skin Sterol Test available for sale in Canada, U.S. markets

IMI to exhibit at 19th Annual Financial Forum in Toronto

New skin sterol data published in Journal of Clinical Chemistry

IMI expands skin sterol research with study examining new cardiovascular disease markers

IMI announces decision not to pursue IBEX Technologies Inc.

New Skin Sterol data to be presented at American College of Cardiology Annual Conference

IMI granted new skin sterol patent in Europe

IMI announces new PREVU(x) study with Montreal Heart Institute

IMI announces third quarter results

IMI to hold third quarter fiscal 2004 conference call & webcast

IMI announces unsolicited takeover offer for IBEX Technologies Inc.

Skin sterol provides new information about heart disease risk

IMI to Present at Rodman & Renshaw Healthcare Conference

IMI International Medical Innovations Retains New York-Based Investor Relations Firm

IME Discussion

Your Recent History